Axis Direct
We maintain our HOLD rating with a target price of Rs 1,580, implying an upside potential of 4%, valuing the company at a PE of 20x for FY27.
Gland Pharma has gained 22.80% in the last 1 Week
More from Gland Pharma Ltd.
Recommended